Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can VR calm the mind after brain injury? tiny study hopes to find out

NCT ID NCT07371260

Symptom relief Sponsor: Hopital La Musse Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether virtual reality relaxation sessions can help adults with acquired brain injury who live in nursing homes and have emotional or behavioral issues. Three participants will use a multisensory VR device for 15–20 minutes twice a week over 8 weeks. Researchers will track changes in their most troubling behaviors and emotional well-being.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
virtual reality relaxation sessions using the VirtySens® multisensory device
What this could lead to
If it works, this could offer a drug-free way to help people with brain injury feel calmer and reduce challenging behaviors in care settings.
What could go wrong
This is a very small early study with only 3 participants, so results may not apply to others. The effect may be small or temporary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 3 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Feb 2026

An estimate. Start dates often move.

Expected to finish

Feb 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Resident aged over 18 * Diagnosis of stroke, traumatic brain injury, tumor, or cerebral anoxia for more than 3 years. * Living in a nursing home for at least 6 months * Presence of one or more emotional and behavioral disorders during initial assessments (NPI-ES) for at least 3 months. * Sufficient cognitive abilities to understand instructions and answer questions using a Likert scale. * Normal or corrected visual acuity * Resident affiliated with the social security system Exclusion Criteria: * Motor or sensory disorders incompatible with the use of VR * Unstabilized photosensitive epilepsy or presence of a seizure in the past year * Change in the prescription of neuroleptic treatments, antidepressants, benzodiazepines, sedatives, anxiolytics, mood stabilizers, antiepileptics, or betablockers within the last 3 months. * Unstabilized major psychiatric disorders. * Craniectomy * Limited range of cervical movement due to orthopedic disorders * Moderate or severe hearing loss not compensated by a hearing aid * Anosmia * Asthma * Pregnant women or women suspected of being pregnant * Breastfeeding women * Neurocognitive disorders preventing understanding of instructions during assessments * The resident is included in another research protocol

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Behavior are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Behavior brain injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Behavior Brain injury Emotion Virtual reality Well being

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Hôpital La Musse

    Saint-Sébastien-de-Morsent, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.